The Gender Gap in Medical Research
For decades, medical research has prioritized men’s health, leaving women’s health research underfunded and understudied. This gender gap in medical research has led to higher misdiagnosis rates, longer diagnosis times, and greater drug safety risks for women.
Even though women make up half the population and face unique biological challenges such as pregnancy, menopause, and autoimmune diseases, medical research bias still favors men. Funding disparities in medical research continue to impact millions of women worldwide. So why is women’s health still overlooked, and what needs to change?
A History of Male-Centric Medical Research
Historically, clinical trials have focused on male subjects, often excluding women due to concerns over hormonal fluctuations affecting results. While this was a way to control variables, it led to severe health disparities. Medical bias against women meant that treatments, medications, and disease studies were designed with male physiology in mind, creating significant gaps in knowledge about how conditions affect women differently.
Key Statistic:
Before the 1990s, women were frequently excluded from clinical trials. Even today, they remain underrepresented in studies for major diseases, impacting drug safety and treatment effectiveness.
Source: Harvard Medical School, 2022
Key Statistic:
One example is heart disease. Women experience different symptoms than men, yet many doctors still rely on male-centric data. A study found that women suffering heart attacks are 50% more likely to be misdiagnosed than men, leading to higher mortality rates.
Source: The British Heart Foundation, 2016
Funding Disparities
Men’s Health vs. Women’s Health
Medical research funding often reflects societal priorities, and unfortunately, women’s health conditions have not been given the attention they deserve.
Here’s how funding disparities in medical research affect different conditions:
Heart Disease
For every $1 spent on coronary artery disease in men, only 80 cents is spent on women—even though heart disease is the leading cause of death for women.
Source: Harvard Medical School, 2022
Alzheimer’s Disease
Women make up two-thirds of all Alzheimer’s patients, yet only 12% of research funding is dedicated to female-specific studies.
Source: Katz Institute for Women’s Health, n.d
Endometriosis
Despite affecting 190 million women worldwide, endometriosis receives far less funding than male conditions like erectile dysfunction.
Source: The National Library of Medicine, 2023
Autoimmune Diseases
Women are four times more likely than men to develop an autoimmune disorder, yet research into these conditions remains underfunded.
Source: The National Library of Medicine, 2023
Maternal Health Research
The U.S. has one of the highest maternal mortality rates among developed countries, yet pregnancy-related conditions like preeclampsia and postpartum depression remain severely underfunded.
Source: World Economic Forum, 2024
The Consequences of Ignoring Women’s Health
The lack of funding and research inclusion has had serious real-world effects on women’s health outcomes:
Higher Misdiagnosis Rates
Women are more likely to be misdiagnosed or experience delayed treatment because many medical guidelines are based on male-centric data.
Source: The Week US, 2024
Drug Safety Issues
Women are twice as likely as men to suffer adverse drug reactions, since most drug trials have historically been conducted on male subjects.
Source: The Week US, 2024
Longer Diagnosis Times
Conditions such as polycystic ovary syndrome (PCOS) and endometriosis take an average of 7-10 years to diagnose due to a lack of research and awareness.
Source: The National Library of Medicine, 2023
Mental Health Disparities
Women are more likely to experience depression and anxiety disorders, yet research into female-specific mental health needs remains underfunded.
Source: The National Library of Medicine, 2023
Discover more stats relating to women’s mental health HERE.
The Need for Change in Medical Research
Change is happening, but slowly. The National Institutes of Health (NIH) now requires researchers to include women in clinical trials, but enforcement remains a challenge. Governments, private organisations, and advocacy groups must prioritise funding for women’s health research to close this gender gap in healthcare.
Investing in women’s health funding isn’t just about equality—it’s about improving healthcare outcomes for everyone. When medical research includes women, it leads to better treatments, safer drugs, and more accurate diagnoses for all.
Time to Close the Gender Gap in Healthcare
For too long, women’s health has been sidelined in medical research, leading to misdiagnoses, ineffective treatments, and preventable deaths.
To bridge this gap, we need:
- More research funding for female-specific conditions
- Equal representation in clinical trials
- Greater awareness of women’s unique health risks
- Policy changes to ensure equitable healthcare research
When we treat women’s health with the same urgency as men’s, we create a healthier future for everyone. It’s time to demand better funding, awareness, and research inclusion—because women’s health matters.
Statistics to Remember
Clinical Trials Representation
Women were historically excluded from clinical trials, and even today, they remain underrepresented in research for many major diseases.
Alzheimer’s Research Funding
Women make up two-thirds of Alzheimer’s patients, yet only 12% of research funding is allocated to studying the disease in women.
Diagnosis Delays for Women’s Conditions
PCOS and endometriosis take an average of 7 to 10 years for a proper diagnosis due to lack of research and awareness.
Endometriosis Research Funding
Despite affecting 190 million women globally, endometriosis receives significantly less funding than conditions like erectile dysfunction.
Funding Bias in Medical Research
In 75% of cases where a disease disproportionately affects one gender, men’s conditions receive more funding, while women’s conditions remain underfunded.
Adverse Drug Reactions in Women
Women experience twice as many adverse drug reactions as men because most medical trials are conducted on male subjects.
Global R&D Funding
Only 5% of global research and development (R&D) funding is dedicated to women’s health, and just 1% is focused on non-cancer female-specific conditions.
Leave your thoughts